Literature DB >> 23986492

Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.

Katy Sinka1, Kimberley Kavanagh, Ruth Gordon, John Love, Alison Potts, Martin Donaghy, Chris Robertson.   

Abstract

BACKGROUND AND METHODS: The national immunisation records of over 220,000 girls offered vaccine in the routine or catch-up programme of the Human papillomavirus (HPV) programme in Scotland were analysed. Descriptive statistics and multilevel modelling were used to determine individual and organisational factors associated with uptake. Age, school year, school denomination, deprivation and, for school-leavers, mode of delivery were explored. Additional aggregate data were used to examine the effect of late uptake of missed doses in the routine vaccination programme.
RESULTS: School-based delivery initially achieved over 80% uptake of complete courses in routine and catch-up age groups. Within this context of generally high coverage, there was an association between individual level deprivation and lower uptake, and a decline in in-year course completion over time. However, later uptake of missed doses in the following year substantially decreased these effects. There was no influence on uptake of the type of school (non-denominational/denominational). Vaccination of school-leavers in the catch-up campaign had lower coverage, with 50% starting and 30% completing the course in-year. There was no clear advantage of vaccination through general practice or through Board-run clinics in reaching this group.
CONCLUSIONS: School-based vaccination can achieve high and equitable uptake of a multidose vaccine in a routine immunisation programme. Sustained high coverage with HPV vaccine across Scotland provides a stable platform for planning future strategies for cervical screening and understanding the impact of the vaccination at a population level.

Entities:  

Keywords:  Adolescents CG; Cancer: Cervix; Immunization; Inequalities; Public Health

Mesh:

Substances:

Year:  2013        PMID: 23986492     DOI: 10.1136/jech-2013-202620

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  28 in total

1.  Improving HPV vaccine delivery at school-based health centers.

Authors:  Kristin Oliver; Colleen McCorkell; Ilana Pister; Noora Majid; Denise H Benkel; Jane R Zucker
Journal:  Hum Vaccin Immunother       Date:  2019-03-15       Impact factor: 3.452

Review 2.  Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer.

Authors:  Rebecca Luckett; Sarah Feldman
Journal:  Hum Vaccin Immunother       Date:  2015-11-20       Impact factor: 3.452

3.  Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.

Authors:  Carine Dochez; Rosemary J Burnett; Symplice Mbola Mbassi; Fred Were; Andrew Musyoki; Daisy Trovoada; M Jeffrey Mphahlele
Journal:  Papillomavirus Res       Date:  2017-09-01

4.  High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.

Authors:  Clare Tanton; Kate Soldan; Simon Beddows; Catherine H Mercer; Jo Waller; Nigel Field; Soazig Clifton; Andrew J Copas; Kavita Panwar; Precious Manyenga; Filomeno da Silva; Kaye Wellings; Catherine A Ison; Anne M Johnson; Pam Sonnenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-03-03       Impact factor: 4.254

5.  Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018.

Authors:  Onyema Greg Chido-Amajuoyi; Rajesh Talluri; Chizoba Wonodi; Sanjay Shete
Journal:  Pediatrics       Date:  2021-05-03       Impact factor: 9.703

6.  Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway.

Authors:  Berit Feiring; Ida Laake; Tor Molden; Inger Cappelen; Siri E Håberg; Per Magnus; Ólöf Anna Steingrímsdóttir; Bjørn Heine Strand; Jeanette Stålcrantz; Lill Trogstad
Journal:  BMJ Open       Date:  2015-05-19       Impact factor: 2.692

7.  Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland.

Authors:  K G J Pollock; K Kavanagh; A Potts; J Love; K Cuschieri; H Cubie; C Robertson; M Cruickshank; T J Palmer; S Nicoll; M Donaghy
Journal:  Br J Cancer       Date:  2014-09-02       Impact factor: 7.640

Review 8.  Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies.

Authors:  Victoria Fernández de Casadevante; Julita Gil Cuesta; Lourdes Cantarero-Arévalo
Journal:  Front Oncol       Date:  2015-06-24       Impact factor: 6.244

Review 9.  Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis.

Authors:  Harriet Batista Ferrer; Caroline Trotter; Matthew Hickman; Suzanne Audrey
Journal:  BMC Public Health       Date:  2014-07-09       Impact factor: 3.295

10.  Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types.

Authors:  K Kavanagh; K G J Pollock; A Potts; J Love; K Cuschieri; H Cubie; C Robertson; M Donaghy
Journal:  Br J Cancer       Date:  2014-04-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.